Literature DB >> 23294591

Epidemiology of hepatitis B and associated liver diseases in china.

Yao Zhang1, Hua Zhang, Au Elizabeth, Xiao-Qing Liu.   

Abstract

Hepatitis B virus (HBV) infection has long been a critical public health challenge in China. National surveys revealed a prevalence of approximate 10% for chronic HBV infection in general population. HBV has been the leading cause of chronic hepatitis, cirrhosis, and liver cancers in Chinese population and a common pathogen of acute viral hepatitis. Meanwhile, the epidemic provided important opportunities to research the natural history, public health impact, and therapeutic and preventive interventions for HBV in China. In this review, we summarized the selected key epidemiological studies since 1970s regarding HBV infection and its associated liver diseases in China, and provided considerations for future research, prevention and treatment of HBV.

Entities:  

Mesh：

Year:  2013        PMID： 23294591     DOI： 10.1016/s1001-9294(13)60009-7

Source DB:  PubMed          Journal:  Chin Med Sci J        ISSN： 1001-9294


  15 in total

1.  Cost-effectiveness of augmenting universal hepatitis B vaccination with immunoglobulin treatment: a case study in Zhejiang Province, East China.

Authors:  Yanbing Zeng; Mingliang Luo; Jianlin Lin; Hanqing He; Xuan Deng; Shuyun Xie; Ya Fang
Journal:  Hum Vaccin Immunother       Date:  2019-11-26       Impact factor: 3.452

2.  Prevalence and risk factors of gallbladder polypoid lesions in Chinese petrochemical employees.

Authors:  Yu-Shan Mao; Yi-Feng Mai; Fu-Jun Li; Yan-Ming Zhang; Ke-Min Hu; Zhong-Li Hong; Zhong-Wei Zhu
Journal:  World J Gastroenterol       Date:  2013-07-21       Impact factor: 5.742

3.  Dose-response association between hepatitis B surface antigen levels and liver cancer risk in Chinese men and women.

Authors:  Yang Yang; Jing Gao; Hong-Lan Li; Wei Zheng; Gong Yang; Wei Zhang; Xiao Ma; Yu-Ting Tan; Nathaniel Rothman; Yu-Tang Gao; Wong-Ho Chow; Xiao-Ou Shu; Yong-Bing Xiang
Journal:  Int J Cancer       Date:  2016-03-30       Impact factor: 7.396

Review 4.  The global burden of liver disease: the major impact of China.

Authors:  Fu-Sheng Wang; Jian-Gao Fan; Zheng Zhang; Bin Gao; Hong-Yang Wang
Journal:  Hepatology       Date:  2014-10-29       Impact factor: 17.425

Review 5.  Better plans and more powerful evidence are needed in the research and treatment of chronic hepatitis B in China.

Authors:  Changtai Zhu; Yulu Gao; Lihui Jiang; Baoqiong Ding; Yongning Sun
Journal:  Int J Clin Exp Med       Date:  2015-12-15

6.  Spatial analysis of the distribution, risk factors and access to medical resources of patients with hepatitis B in Shenzhen, China.

Authors:  Yuliang Xi; Fu Ren; Shi Liang; Jinghua Zhang; De-Nan Lin
Journal:  Int J Environ Res Public Health       Date:  2014-11-07       Impact factor: 3.390

7.  The Seroprevalence of Hepatitis B in Akbar Abad Village, Kavar, Southern Iran.

Authors:  Mohammad Reza Fattahi; Davood Mehrabani; Sara Mehvarz; Najmeh Zarei Jaliani; Abbas Alipour; Mohammad Ali Davarpanah
Journal:  Int J Prev Med       Date:  2014-12

8.  Perioperative and long-term outcomes of liver resection for hepatitis B virus-related hepatocellular carcinoma without versus with hepatic inflow occlusion: study protocol for a prospective randomized controlled trial.

Authors:  Yinzhe Xu; Jiye Chen; Hongguang Wang; Hui Zheng; Dan Feng; Aiqun Zhang; Jianjun Leng; Weidong Duan; Zhanyu Yang; Mingyi Chen; Xianjie Shi; Shouwang Cai; Wenbin Ji; Kai Jiang; Wenzhi Zhang; Yongliang Chen; Wanqing Gu; Jiahong Dong; Shichun Lu
Journal:  Trials       Date:  2016-10-11       Impact factor: 2.279

9.  Serum Metabolomics to Identify the Liver Disease-Specific Biomarkers for the Progression of Hepatitis to Hepatocellular Carcinoma.

Authors:  Rong Gao; Jianhua Cheng; Chunlei Fan; Xiaofeng Shi; Yuan Cao; Bo Sun; Huiguo Ding; Chengjin Hu; Fangting Dong; Xianzhong Yan
Journal:  Sci Rep       Date:  2015-12-10       Impact factor: 4.379

10.  Relationship between platelet parameters and hepatic pathology in patients with chronic hepatitis B infection - a retrospective cohort study of 677 patients.

Authors:  Ye Pan; Aikeremujiang Muheremu; Xiaolu Wu; Jiajun Liu
Journal:  J Int Med Res       Date:  2016-06-21       Impact factor: 1.671
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.